Antimicrobial Drug Resistance 2017
DOI: 10.1007/978-3-319-47266-9_5
|View full text |Cite
|
Sign up to set email alerts
|

Resistance in Aerobic Gram-Positive Bacilli

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 159 publications
0
1
0
Order By: Relevance
“…It is reported to have higher activity against Gram‐negative and anaerobic bacteria (Falagas, Mavroudis, & Vardakas, ). Moxifloxacin has been used to treat infections of varied etiology, such as those found in the respiratory tract, intra‐abdominal infections, endocarditis, and meningities (Weber, Miller, & Rutala, ). The drug is said to inhibit the enzymes DNA gyrase and topoisomerase IV (Ehrmann, Jolivet‐Gougeon, Bonnaure‐Mallet, & Fosse, ).…”
Section: Resultsmentioning
confidence: 99%
“…It is reported to have higher activity against Gram‐negative and anaerobic bacteria (Falagas, Mavroudis, & Vardakas, ). Moxifloxacin has been used to treat infections of varied etiology, such as those found in the respiratory tract, intra‐abdominal infections, endocarditis, and meningities (Weber, Miller, & Rutala, ). The drug is said to inhibit the enzymes DNA gyrase and topoisomerase IV (Ehrmann, Jolivet‐Gougeon, Bonnaure‐Mallet, & Fosse, ).…”
Section: Resultsmentioning
confidence: 99%